Blockchain Registration Transaction Record

Tonix Pharmaceuticals to Showcase Rheumatology Advances at EULAR 2025

Tonix Pharmaceuticals to present at EULAR 2025, advancing rheumatologic treatments and fibromyalgia therapy TNX-102 SL, under FDA review. Read more.

Tonix Pharmaceuticals to Showcase Rheumatology Advances at EULAR 2025

This news highlights Tonix Pharmaceuticals' pivotal role in developing innovative treatments for fibromyalgia and other conditions, potentially improving the quality of life for millions. Their work on TNX-4200 also addresses critical national security needs by protecting military personnel from biological threats, showcasing the company's broad impact on both healthcare and defense sectors.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x5bd129384bc5f03f60bcc34146d0db8806dcecfdc7e965459ed3a3ae12f16c62
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprinturge5fGR-7c3f73f435ddddafed6b026f5af2fc15